Table 1.
Baseline Patient Characteristics
| Characteristic | Control (n = 105) | Intervention (n = 112) |
|---|---|---|
| Age, median (IQR), y | 58 (50–64) | 53 (45–61)a |
| Older adult ≥65 y, No. (%) | 21 (20.0) | 17 (15.2) |
| Nonwhite race/ethnicity, No. (%) | 63 (60.0) | 81 (72.3) |
| Female sex, No. (%) | 59 (56.2) | 63 (56.3) |
| Household annual income <$10,000, No. (%) | 54 (51.4) | 47 (42.0) |
| <High school education, No. (%) | 46 (43.8) | 40 (35.7) |
| No private insurance, No. (%) | 77 (73.3)a | 66 (58.9) |
| Covered by Medicaid or Medicare, No. (%) | 50 (47.6) | 43 (38.4) |
| Baseline glycosylated hemoglobin level, median (IQR), % | 10.1 (9.1–11.5) | 10.5 (9.1–12.2) |
| Duration of diabetes, median (IQR), y | 6 (1.25–12.50) | 5 (1.63–11.00) |
| Presence of neuropathy, No. (%) | 43 (41.0) | 41 (36.6) |
| Use of insulin at enrollment, No. (%) | 40 (38.1) | 45 (40.2) |
IQR indicates interquartile range.
a
P <.05 (P ≥ .05 for all other comparisons).